Latest Deals

Credit: 

Swedish company Getinge announced plans to take over High Purity New England (HPNE) in a deal worth up to $290 million. 

HPNE supplies products that help biopharmaceutical and biotechnology players in the production of monoclonal antibodies, vaccines, cell and gene therapies and other next-generation therapies. The range of products include drug discovery and upstream and downstream processing. 

Avacta Group has acquired Coris BioConcept for £7.4 million ($9.2 million) with an earnout based on future business performance, payable in cash, of up to £3 million. Coris BioConcept, based in Belgium and established in 1996, manufactures and markets a variety of lateral flow tests for use in the healthcare industry. The acquisition enables the company to tap into the rapid medical diagnostic kits market, which is forecast to reach a value of $23.1 billion by 2031.

Paris based software company, BrightHeart has raised €2 million ($2.1 million) to develop its artificial intelligence (AI) technology for detecting heart conditions in foetuses. The AI-driven software uses data from 20,000 foetal exams to detect early signs of heart conditions.

Tissue reconstruction company Tissium has secured €50m ($53.8m) in Series D financing round to launch its platform of biomorphic programmable polymers. Based in Paris, France and Boston, USA, the privately-owned company’s  has a pipeline of seven products.